dual PD-1 checkpoint inhibitor/PD-L1 checkpoint inhibitor (Crossignal Therapeutics)

N/A

Report date: 2025/03/18 18:12:00
NME

Base Information

Drug Namedual PD-1 checkpoint inhibitor/PD-L1 checkpoint inhibitor (Crossignal Therapeutics)
Drug Alias NamePD-1 checkpoint inhibitor/PD-L1 checkpoint inhibitor (Crossignal Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProgrammed death-ligand 1 blockersProgrammed cell death protein 1 blockers
TargetsProgrammed death-ligand 1Programmed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrossignal Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCrossignal Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A